611 filings
Page 2 of 31
8-K
MSLPQ
MusclePharm Corp
9 Jun 22
Entry into a Material Definitive Agreement
4:27pm
8-K
MSLPQ
MusclePharm Corp
17 May 22
MusclePharm Announces First Quarter 2022 Financial Results
4:15pm
10-Q
2022 Q1
MSLPQ
MusclePharm Corp
Quarterly report
16 May 22
4:42pm
8-K
MSLPQ
MusclePharm Corp
5 May 22
Company Delivers $10.0 Million of Net Revenue in Fourth Quarter 2021 and $50.0 Million of Net Revenue for Full Year 2021
4:55pm
10-K/A
2021 FY
MSLPQ
MusclePharm Corp
Annual report (amended)
4 May 22
4:29pm
8-K
MSLPQ
MusclePharm Corp
28 Apr 22
MusclePharm Announces Fourth Quarter and Fiscal Year 2021 Financial Results
8:15am
10-K
2021 FY
MSLPQ
MusclePharm Corp
Annual report
15 Apr 22
5:31pm
SC 13D/A
MSLPQ
MusclePharm Corp
1 Apr 22
MusclePharm / White Winston Select Asset Fund Series Fund MP-18 ownership change
4:38pm
4
White Winston Select Asset Fund Series Fund MP-18, LLC
31 Mar 22
MusclePharm / MARK BLUNDELL ownership change
7:19pm
NT 10-K
MSLPQ
MusclePharm Corp
31 Mar 22
Notice of late annual filing
4:00pm
8-K
MSLPQ
MusclePharm Corp
11 Mar 22
Entry into a Material Definitive Agreement
4:55pm
SC 13D/A
White Winston Select Asset Fund Series Fund MP-18, LLC
22 Feb 22
MusclePharm / White Winston Select Asset Fund Series Fund MP-18 ownership change
11:22am
8-K
MSLPQ
MusclePharm Corp
29 Dec 21
Departure of Directors or Certain Officers
4:04pm
10-Q
2021 Q3
MSLPQ
MusclePharm Corp
Quarterly report
17 Nov 21
6:02am
8-K
MSLPQ
MusclePharm Corp
15 Nov 21
MusclePharm Announces Third Quarter 2021 Financial Results
9:52pm
NT 10-Q
MSLPQ
MusclePharm Corp
15 Nov 21
Notice of late quarterly filing
9:33pm
8-K
MSLPQ
MusclePharm Corp
2 Nov 21
Entry into a Material Definitive Agreement
2:00pm
UPLOAD
MSLPQ
MusclePharm Corp
20 Oct 21
Letter from SEC
12:00am
8-K
MSLPQ
MusclePharm Corp
19 Oct 21
Entry into a Material Definitive Agreement
12:00am
CORRESP
MSLPQ
MusclePharm Corp
15 Oct 21
Correspondence with SEC
12:00am